| Financial Year |
March 31 2023 |
| Monetary Funds |
3,368,676,453.00 |
| Held-for-trading Financial Assets |
10,000,000.00 |
| Notes Receivable |
1,082,695,497.44 |
| Accounts Receivable |
3,455,098,982.80 |
| Advances to Suppliers |
1,146,579,101.81 |
| Other Receivables |
148,249,748.70 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,416,535,696.31 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
209,109,236.35 |
| Total Current Assets |
11,160,272,532.18 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
372,711,869.10 |
| Investment Properties |
-- |
| Fixed Assetes |
15,571,621,434.99 |
| Under-construction Projects |
4,166,885,439.32 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,220,656,868.00 |
| R&D expenses |
-- |
| Goodwill |
3,360,477,870.19 |
| Long-Term Deferred and Prepaid Expenses |
479,540,834.90 |
| Deferred Income Tax Assets |
134,474,319.17 |
| Other Non-Current Assets |
435,011,797.10 |
| Sub-Total of Non-Current Assets |
28,296,873,514.44 |
| Total Assets |
39,457,146,046.62 |
| Short-Term Loans |
2,885,157,555.50 |
| Trading Financial liabilities |
-- |
| Notes Payable |
84,459,665.97 |
| Accounts Payable |
4,710,006,068.67 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
317,625,052.43 |
| Taxes Payable |
238,711,484.59 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,294,814,499.09 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,059,110,400.31 |
| Other Current Liabilities |
7,519,581,063.63 |
| Sub-Total of Current Liabilities |
21,488,132,939.83 |
| Long-term Loans |
1,168,066,464.79 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
28,858,286.12 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
449,234,722.29 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,106,643,132.34 |
| Total Liabilities |
23,594,776,072.17 |
| Paid-In Capital(Or Share Stock) |
2,876,730,494.00 |
| Capital Surplus |
1,926,609,476.47 |
| Surplus Reserve |
916,171,441.55 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
6,644,895,253.90 |
| Minority Stockholder's Interest |
2,455,366,759.96 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
13,407,003,214.49 |
| Owner's Equity（Stockholder's Equity） |
15,862,369,974.45 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
39,457,146,046.62 |
